Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
17.81
+0.93 (5.51%)
Nov 4, 2024, 4:00 PM EST - Market closed
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $1.36 billion as of November 4, 2024. Its market cap has increased by 122.33% in one year.
Market Cap
1.36B
Enterprise Value
890.07M
1-Year Change
122.33%
Ranking
Category
Stock Price
$17.81
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $1.36B, an increase of 1,100.40%. That is a compound annual growth rate of 31.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 1.36B | 27.80% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 1.37B |
| Progyny | 1.37B |
| Pharvaris | 1.36B |
| Cogent Biosciences | 1.32B |
| Enliven Therapeutics | 1.32B |
| Establishment Labs Holdings | 1.31B |
| Schrödinger | 1.31B |
| AdaptHealth | 1.29B |